VAQTA
VAQTA
Approved
DIN Number
02229702
Drug Class
Human
Market Date
Nov 10, 1996
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02229702
AIG Number0126318003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BC02 HEPATITIS A, INACTIVATED, WHOLE VIRUS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
HEPATITIS A VACCINE, INACTIVATEDActive
Strength: 50 UNIT / ML
Monograph: HEPATITIS A VACCINE, INACTIVATED